Comparative studies have shown that Wistar Ottawa Karlsburg W (RT1 u ) rats (WOKW) develop a nearly complete metabolic syndrome with obesity, moderate hypertension, dyslipidemia, hyperinsulinemia, and impaired glucose tolerance up to an age of 28 weeks. Because metabolic data thereafter are missing, WOKW and diseaseresistant DA rats were studied for 12 months beginning at an age of 5 months. METHODS: Eighteen male inbred WOKW and DA rats were studied monthly from the 5th to the 17th month of life for traits of the metabolic syndrome such as body weight, body mass index (BMI), serum triglycerides, total cholesterol, leptin, insulin as well as glucose tolerance, 24 h excretion of urine total protein and creatinine including telemetric measurement of blood pressure in six males per each group. RESULTS: Except for serum total cholesterol, the measured values for most traits studied were significantly higher in WOKW than in DA rats at an age of 5 months. At an age of 17 months all traits were significantly elevated in WOKW compared with DA rats. WOKW rats were hypertensive, dyslipidemic, obese, glucose intolerant, hyperinsulinemic and proteinuric. CONCLUSION: Considering the phenotype of the WOKW rat described until now and the fact that the metabolic syndrome in this rat is polygenetically determined, the WOKW rat is the most suitable animal model to study the pathophysiology of the facets of the syndrome.
Introduction
Studies in humans have shown clustering of hyperinsulinemia, glucose intolerance, dyslipidemia, hypertension and obesity, 1 -3 which has been referred to as the metabolic syndrome. Much of our understanding of the aetiopathogenesis of facets of the metabolic syndrome comes from studies using animal models. However, most experimental studies have been carried out with models developing genetically determined obesity, hypertension or dyslipidemia. 4 -6 Studies with an animal model developing a complete metabolic syndrome including all the above-mentioned disorders were recently described. 7 Comparative studies have shown that the Wistar Ottawa Karlsburg W (RT1 u ) rat strain (WOKW) develops a nearly complete metabolic syndrome with obesity, moderate hypertension, dyslipidemia, hyperinsulinemia and impaired glucose tolerance. In addition, a cross-sectional comparative study indicated that the WOKW rat begins to manifest the signs of the metabolic syndrome between 8 and 10 weeks of age. 8 Genetic studies using a (WOKWÂDA)F 2 hybrid population clearly demonstrated that the metabolic syndrome in WOKW rats is under polygenic control. 9, 10 To date, sufficient data has been reported on phenotypic characterization of WOKW rats up to an age of 30 weeks, but metabolic data thereafter are missing. That prompted us to characterize WOKW and disease-resistant DA rats up to an age of 17 months for traits relevant to the pathophysiology of the metabolic syndrome.
Material and methods
The inbred WOKW=K (F 62) and DA=K (F 75) strains were bred and kept in our own animal facility. The rats were housed in groups of three in Macrolon type III cages (Ehret GmbH, Emmendingen, Germany) under strict hygienic conditions and were maintained at 12 h light and dark cycle (5 am= 5 pm). All rats were free of major pathogens as described previously 11 and had free access to food (Ssniff 1 ; Soest, Germany) and acidulated water.
Eighteen male WOKW and 18 male DA rats were studied monthly from the 5th to 17th months of life, when the first animals died. The body weight and the body length of rats were determined to calculate the body mass index (BMI). Blood samples were obtained from fed WOKW and DA rats by orbital puncture while they were under light anesthesia (Sevofluran, Abbott, Germany) between 7 and 9 am.
Serum triglycerides and total cholesterol were analyzed using an automatic analyzer (Roche Cobas Mira Plus, Roche, Switzerland). Serum leptin and insulin were determined using radioimmunoassay kits (Rat Insulin and Leptin RIA Kit; Linco Research, St Charles, MO, USA). Twenty-four-hour excretion of urine total protein and creatinine were determined using metabolic cages (Ehret GmbH, Emmendingen, Germany). To measure glucose tolerance, animals were intraperitoneally injected with 2 g-glucose=kg body weight. Blood samples were obtained from tail vein before (0) and 60 min after glucose load. Blood glucose was determined using a glucose analyser (ESAT 6660-2, Medingen, Germany).
For telemetric measurement of blood pressure, six males of each strain were implanted a transmitter (Model TA11PA-C40, Data Sciences International, St Paul, MN, USA) as described in detail. 12 The blood pressure data were registered every 5 min for four consecutive days per month.
All experiments were performed in accordance with the rules for animal care of the Ministry of Nutrition, Agriculture and Forestry of the German Government and were approved by the Institution's animal care and use committee.
Results are presented as means AE s.d. (Table 1) or as means AE s.e.m. (Figure 1 ). For blood pressure the data processing DQSORT (Data Sciences International, St Paul, MN, USA) was used. Differences for each phenotypic trait between WOKW and DA rats were assessed by ANOVA using the SPSS computer program (SPSS, Chicago, IL, USA).
Results and discussion
As shown in Table 1 , five out of six traits studied were significantly different between WOKW and DA rats at an age of 5 months. Comparable values were only observed in serum total cholesterol. At an age of 5 months the BMI of Metabolic syndrome in WOKW J van den Brandt et al WOKW rats was significantly higher than that in DA and serum triglycerides were more than three times, serum insulin three times and serum leptin levels more than two times higher in WOKW than in DA. The glucose tolerance measured 60 min after glucose load suggests intolerance in WOKW at this age. Comparing WOKW and DA rats at an age of 17 months, all traits studied were significantly and impressively higher in WOKW than in DA rats as shown in Table 1 . In comparison with an age of 5 months, BMI was additionally increased in WOKW and the differences between WOKW and DA were greater than those found at an age of 5 months. The serum cholesterol, triglyceride, insulin and leptin levels were markedly increased in WOKW rats at an age of 17 months. In contrast, the measured values in DA rats increased to much lower extent than observed in WOKW or the values even remained nearly constant. In addition, also the glucose tolerance was more impaired in WOKW after 17 months compared with 5 months and in comparison with DA. As demonstrated in Figure 1 , 5-month-old WOKW rats were characterized by a significantly elevated blood pressure compared with DA rats. The blood pressure difference between WOKW and DA increased with age. At the end of the observation period WOKW rats developed hypertension. The blood pressure values amounted to 160 mmHg. In the total protein excretion a slight elevation was observed in WOKW rats up to 10 months. From 11 to 14 months, the protein excretion moderately increased, but thereafter a markedly increased protein excretion was found. The creatinine clearance of WOKW rats was significantly lower than in DA rats. As shown in Figure 1 , the clearance continuously dropped in WOKW rats, whereas in DA rats the clearance was comparable at the beginning and at the end of the observation period, but varying between both time points.
In accordance with the WHO proposal, 13 the components of the metabolic syndrome are: (1) hypertension, defined as elevated systolic blood pressure; (2) dyslipidemia, defined as elevated plasma triglycerides and=or low HDL cholesterol concentrations; (3) obesity, defined as a high BMI; and (4) microalbuminuria. Considering this definition, the WOKW rat doubtlessly develops a complete metabolic syndrome, which is obviously pronounced in the course of its lifetime. WOKW rats are characterized by increasing blood pressure, serum triglycerides and total cholesterol, BMI and serum leptin, impaired glucose tolerance, insulin resistance, proteinuria and impaired creatinine clearance. In particular, the total protein excretion, which dramatically increased with age, similarly to blood pressure and serum lipids, could be a hint proposing that WOKW rats also have a high risk of developing cardiovascular disease. This assumption is supported by studies in humans, which have clearly shown that already microalbuminuria is a strong predictor of cardiovascular morbidity and mortality in patients with impaired glucose tolerance and hypertension. 14 -16 Therefore, WOKW rats might develop cardiovascular disease. An assumption supported by our observation that some WOKW rats at higher age ( > 20 months) developed black tail ends diagnosed as Gangraena sicca. Nevertheless, all assumptions will need to be supported by experimental evidence.
Considering all phenotypic findings described until now and the fact that the metabolic syndrome in WOKW rats is polygenetically determined, 7 -10 the WOKW rat is an excellent and unique animal model to study the pathophysiology of the facets of the syndrome. WOKW rat will not only help to advance our understanding of the syndrome, but also assist the development and testing of new therapeutic strategies reducing the burden of the syndrome in humans.
